ACADIA PHARMACEUTICALS INC's ticker is ACAD and the CUSIP is 004225108. A total of 183 filers reported holding ACADIA PHARMACEUTICALS INC in Q3 2015. The put-call ratio across all filers is 1.98 and the average weighting 0.2%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2015 | $22,745,000 | +7.8% | 638,000 | 0.0% | 0.10% | +10.5% |
Q3 2015 | $21,099,000 | -21.2% | 638,000 | -0.2% | 0.10% | -9.5% |
Q2 2015 | $26,766,000 | +35.3% | 639,100 | +5.3% | 0.10% | +36.4% |
Q1 2015 | $19,785,000 | +25.2% | 607,100 | +22.0% | 0.08% | +22.2% |
Q4 2014 | $15,797,000 | +27.1% | 497,530 | -0.9% | 0.06% | +23.5% |
Q3 2014 | $12,432,000 | +25.9% | 502,100 | +14.9% | 0.05% | +30.8% |
Q2 2014 | $9,872,000 | -17.6% | 437,000 | -11.3% | 0.04% | -20.4% |
Q1 2014 | $11,981,000 | – | 492,442 | – | 0.05% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
Baker Brothers Advisors | 28,439,114 | $590,396,000 | 3.89% |
GREAT POINT PARTNERS LLC | 1,196,098 | $24,831,000 | 3.87% |
EMORY UNIVERSITY | 196,601 | $4,081,000 | 2.67% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
Ghost Tree Capital, LLC | 500,000 | $10,380,000 | 2.21% |
NEXTHERA CAPITAL LP | 500,000 | $10,380,000 | 1.99% |
Palo Alto Investors LP | 1,684,180 | $34,964,000 | 1.41% |
Opus Point Partners Management, LLC | 20,828 | $432,000 | 1.03% |
Opaleye Management Inc. | 195,000 | $4,048,000 | 1.03% |
GARRISON BRADFORD & ASSOCIATES INC | 48,500 | $1,007,000 | 0.81% |